These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15499166)

  • 21. Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination.
    Sengupta P; Chatterjee B; Pal TK
    Regul Toxicol Pharmacol; 2017 Dec; 91():151-158. PubMed ID: 29107617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.
    Ieiri I; Nishimura C; Maeda K; Sasaki T; Kimura M; Chiyoda T; Hirota T; Irie S; Shimizu H; Noguchi T; Yoshida K; Sugiyama Y
    Pharmacogenet Genomics; 2011 Aug; 21(8):495-505. PubMed ID: 21691256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic simulations and AUC: center specificity in the limited sampling model.
    Proost JH
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):292-3; author reply 293-5. PubMed ID: 16800102
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety, efficacy, and pharmacokinetics of telmisartan in pediatric patients with hypertension.
    Wells TG; Portman R; Norman P; Haertter S; Davidai G; Fei Wang
    Clin Pediatr (Phila); 2010 Oct; 49(10):938-46. PubMed ID: 20724342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3.
    Shimizu K; Takashima T; Yamane T; Sasaki M; Kageyama H; Hashizume Y; Maeda K; Sugiyama Y; Watanabe Y; Senda M
    Nucl Med Biol; 2012 Aug; 39(6):847-53. PubMed ID: 22421430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects.
    Young CL; Dias VC; Stangier J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1323-30. PubMed ID: 11185630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats.
    Hao K; Chen YC; Cao YG; Yu D; Liu XQ; Wang GJ
    Acta Pharmacol Sin; 2007 May; 28(5):738-43. PubMed ID: 17439731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The involvement of organic anion transporting polypeptide in the hepatic uptake of telmisartan in rats: PET studies with [¹¹C]telmisartan.
    Takashima T; Hashizume Y; Katayama Y; Murai M; Wada Y; Maeda K; Sugiyama Y; Watanabe Y
    Mol Pharm; 2011 Oct; 8(5):1789-98. PubMed ID: 21812443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telmisartan: a review of its use in hypertension.
    Sharpe M; Jarvis B; Goa KL
    Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
    Freytag F; Schelling A; Meinicke T; Deichsel G;
    Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telmisartan.
    McClellan KJ; Markham A
    Drugs; 1998 Dec; 56(6):1039-44; discussion 1045-6. PubMed ID: 9878991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers.
    Yamada A; Maeda K; Ishiguro N; Tsuda Y; Igarashi T; Ebner T; Roth W; Ikushiro S; Sugiyama Y
    Pharmacogenet Genomics; 2011 Sep; 21(9):523-30. PubMed ID: 21829131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers.
    Jeon JY; Im YJ; Kim Y; Han SM; Jo MJ; Shin DH; Yoo JS; Moon BK; Kim BK; Lee BH; Choi YH; Cho BS; Jang HY; Chae SW; Kim MG
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1296-9. PubMed ID: 23030309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of telmisartan, valsartan and candesartan on mycophenolate mofetil pharmacokinetics in Japanese renal transplant recipients.
    Miura M; Satoh S; Kagaya H; Saito M; Inoue T; Ohkubo T; Habuchi T; Suzuki T
    J Clin Pharm Ther; 2009 Dec; 34(6):683-92. PubMed ID: 20175802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telmisartan.
    Bakheit AH; Abd-Elgalil AA; Mustafa B; Haque A; Wani TA
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():371-429. PubMed ID: 26051689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.
    Stangier J; Su CA; Hendriks MG; van Lier JJ; Sollie FA; Oosterhuis B; Jonkman JH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1373-9. PubMed ID: 11185636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.